Updated 5-Year Local Control (Lc), Metastasis-Free Survival (Mfs), And Overall Survival (Os) Data From A Phase I Study Of Nilotinib Plus Radiation (Rt) In High-Risk Chordoma.
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要